PermeaDerm — Topline data
2026
Cohealyx I study fully enrolled, and PermeaDerm I study surpassed 75% enrollment, in December 2025; data from both clinical studies expected in 2026.Source filing
RCEL biotech catalysts & pipeline
AVITA MEDICAL INC · Data as of 2026-09-08
Upcoming catalysts
RECELL — Regulatory decision
2026
CMS is expected to issue final rules later this year, with implementation effective January 1, 2027.Source filing